OIS X 600 wide

NOMINEES

Below is a preview of who has been nominated to date in the 6 OISX Ophthalmology Innovator Awards categories.

CLICK HERE TO SUBMIT YOUR NOMINATION 

The Clinical Innovator Award

  • Daniel Schwartz, MD - Professor of ophthalmology at UCSF
  • Eric Donnenfeld, MD - OCLI/NYU School of Medicine
  • David Sretavan, MD, PhD, Professor of Ophthalmology & Physiology - UCSF
  • Thomas Ciulla, MD - Midwest Eye Institute / VP, Strategy Lead, Ophthalmology - Spark Therapeutics
  • Cadmus Rich, MD, Chief Medical Officer - Aura Biosciences
  • Howard Mayer, MD, Chief Medical Officer - Shire
  • Vance Thompson, MD - Vance Thompson Vision
  • Malik Kahook, MD Professor of Ophthalmology, Vice Chairman, and the Slater Family Endowed Chair in Ophthalmology - University of Colorado School of Medicine
  • Albert M Maguire, MD - Children's Hospital of Philadelphia / Principal Investigator - Spark Therapeutics
  • Sean Ianchulev, Professor - New York Eye and Ear Infirmary/Founder & Chairman of IanTech
  • Stephen R Russell, MD - University of Iowa / Principal Investigator - Spark Therapeutics
  • Arthur Cummings, MD (Product Contoura Vision from Alcon)

The Industry Innovator Award

  • Ron Sandoval, CEO - Provision Diagnostics
  • Michael Abramoff, MD, President & Director - IDx
  • Susan Benton, Head of Global Franchise Strategy and New Products, Ophthalmology - Shire
  • Sean Ianchulev, Professor at New York Eye and Ear Infirmary / Founder & Chairman - IanTech
  • Robert Dempsey, Group Vice President & Head of Global Ophthalmics Franchise - Shire
  • John Hendrick, CEO - Zepto
  • Thomas Ciulla, MD - Midwest Eye Institute / VP, Strategy Lead, Ophthalmology - Spark Therapeutics
  • Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec
  • Michael Ackermann, Chairman - Oyster Point Pharmaceuticals
  • Monty Montoya , President & CEO - CorneaGen
  • Vicente Anido, PhD, CEO & Chairman - Aerie Pharmaceuticals
  • Tom Burns, President & CEO - Glaukos
  • Tom Frinzi, Worldwide President, Surgical - Johnson & Johnson Vision

The Game Changer Award 

  • Cedric Francois, MD & the Apellis Pharmaceuticals team
  • Jeff Marrazzo & the Spark Therapeutics team for Luxturna
  • Shire for Xiidra
  • Mynosys Cellular Devices team for Zepto
  • Elisabet de los Pinos, PhD & the Aura Biosciences team
  • Graybug Vision team
  • Burton Tripathi, CEO & CTO - True Vision Systems
  • Paul McLean, CEO - ClarVista
  • Malik Kahook, MD Professor of Ophthalmology, Vice Chairman, and the Slater Family Endowed Chair in Ophthalmology - University of Colorado School of Medicine
  • Glaukos team
  • CheckedUp team
  • J&J Vision R&D team for the Symfony EDOF IOL
  • Eugene De Juan, Jr., MD & ForSight VISION4 team
  • Leo Lens Technology team
  • Aerie Pharmaceuticals
  • Guy Kezirian - Physician CEO program at Kellogs

The Clinical Rising Star Award 

  • John Berdahl, MD - Vance Thompson Vision / Founder & CEO - Equinox
  • Osamah J. Saeedi, MD, Associate Professor and Director of Clinical Research at the University of Maryland School of Medicine’s Department of Ophthalmology and Visual Sciences in Baltimore, Maryland
  • Ophthalmic Oncology Service - Harkness Eye Institute
  • Justis Ehlers, MD - Cole Eye Institute
  • Gary Wortz, MD - Koffler Vision Group / Founder & Chief Medical Officer - Omega Ophthalmics
  • Riccardo Vinciguerra, MD - Royal Liverpool and Broadgreen University Hospitals
  • Malik Kahook, MD, Professor of Ophthalmology, Vice Chairman, and the Slater Family Endowed Chair in Ophthalmology - University of Colorado School of Medicine

The Industry Rising Star Award 

  • Abdiel Marin, President & CEO - EyeMD EMR Healthcare Systems
  • Yari Mitchell, Vice President of Global Medical Affairs & Business Strategy - AcuFocus
  • Kfir Azoulay, VP & Head, Corporate Strategy - Heidelberg Engineering
  • Elisabet de los Pinos, PhD, CEO - Aura Biosciences
  • Bill Meury, Chief Commercial Officer - Allergan
  • Michael Ackermann, Chairman - Oyster Point Pharmaceuticals
  • Richard Awdeh MD, Founder & CEO - Checked Up
  • Franziska Ullrich, CEO - Ophthorobotics
  • Kenny Key, Chief Operating Officer - Leo Lens

The Dealmakers of the Year Award 

  • Gemini Therapeutics - $42.5M Series A
  • Oyster Point Pharma - $22M Series A
  • Aura Biosciences - $30M Series C
  • Eyenovia IPO - $23.7M
  • Apellis Pharma - $150M
  • ClarVista Medical acquired by Alcon - undisclosed
  • EyePoint Pharma (pSivida + ICON) - $60.5 million of development capital from EW Healthcare Partners and other undisclosed investors as well as $20 million of senior secured debt financing from SWK Holdings